Adjuvant Capital — Full Portfolio
23 tracked investments · listed companies and verified rows first
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.
BiotechHealthtechMenlo Park, US
Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Sanjay Chanda(Chief Development Officer)inLucy O. Day(Chief Financial Officer)in
Co-investorsBioRock VenturesFlucas VenturesMountain Group CapitalRA CapitalBiotechnology Value FundHatteras Venture Partners
Evofem Biosciences is a biopharmaceutical company that commercializes products for women's sexual and reproductive health, including PHEXX, a non-hormonal prescription vaginal contraceptive gel applied before intercourse, and SOLOSEC, an oral antimicrobial agent for treating bacterial vaginosis and trichomoniasis.
BiotechSan Diego, US
Ivy Zhang(Executive Officer)inSaundra Pelletier(Executive Officer, Director)inKelly Culwell(Executive Officer)inJustin J. File(Executive Officer)inAlexander A. Fitzpatrick(Executive Officer)Russell Barrans(Executive Officer)
Co-investorsDomain AssociatesInvescoWoodford Investment Management
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone CapitalEQT Life Sciences+2 more
54Gene conducts genomics research and provides related services to increase the representation of African genetic data in medical research, which aims to advance healthcare solutions globally.
HealthtechWellness & FitnessLagos, NG
Gatumi Aliyu(Founder)inAbasi Ene-Obong(Founder)inOgochukwu Francis Osifo(Founder)in
Co-investorsEndeavor CatalystFifty YearsThe Raba PartnershipV8 Capital PartnersY Combinator
Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Karl Y. Hostetler(Executive Officer, Director)inGail Maderis(Director)inKristine Ball(President & CEO)inElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRaju Gadiraju(Executive Officer)in
Co-investorsBrace PharmaCanaan PartnersLumira VenturesMPM BioImpactOUP (Osage University Partners)Sofinnova Ventures+3 more
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)inGregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)inAxel Scherer(Director)
BoardJustin Klein(Director)in
Co-investorsGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain AssociatesDomain Partners+2 more
Codagenix develops viral vaccines and virotherapeutics using codon deoptimization, a method for engineering attenuated viruses.
BiotechDeep TechHealthtechFarmingdale, US
John Robert Coleman(Executive Officer, Director)Steffen Mueller(Co-Founder, President & Chief Scientific Officer)inCharlie Petty(Director)Steven Winick(Director)Jill Howe(Director)Paul Grint(Executive Chairman & Interim CEO)in
Co-investorsIn-Q-TelTopspin Partners
Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases.
BiotechHealthtech
George Simeon(CEO)inGregory S. Curhan(CFO)Guy De La Rosa(CMO)in
Co-investorsOrbiMedRA CapitalSanofi VenturesHBM Healthcare InvestmentsJanus Henderson InvestorsMedicxi
Evofem Biosciences develops non-hormonal contraceptive and women's sexual health products, including the vaginal gel Phexxi® and the antibiotic SOLOSEC®.
BiotechDigital HealthFemTechHealthtechMedical Devices
Saundra Pelletier(Chief Executive Officer, President and Executive Director)
Co-investorsAtinum Investment Co. Ltd.
Frontier Nutrition makes fortified snacks aimed at improving pediatric and maternal nutrition, focusing on affordability and cultural relevance for low-income communities.
Advanced ManufacturingConsumerFoodTechImpact & Social GoodHastings On Hudson, US
Tanveer Ali(Co-Founder & CFO, Director)Eddie Bearnot(Co-Founder & CEO, Chairman)Rob Beudeker(Director)Shazi Visram(Director)Paul Levy(Director)
Co-investorsStartup Bangladesh
X-vax Legend sells "Nagapetir" branded decorative stickers with various designs for use on motorcycles, cars, laptops, helmets, and community or brand promotion.
E-commerce
Co-investorsScientia Ventures
InDevR develops off-the-shelf and custom analytical testing solutions, including its VaxArray microarray platform and multiplex immunoassays, for the development, optimization, and manufacturing of mRNA-, protein-, polysaccharide, conjugate, and viral vector-based vaccines.
BiotechHardwareHealthtechMedical DevicesBoulder, US
Kathy Rowlen(Co-founder, Scientific Advisor (former CEO))inShannon Rodriguez(Chief Operations Officer)inErica Dawson(Chief Technical Officer)inCraig Hoechstetter(Chief Commercial Officer)inMichael Chang(Director)Laura Kuck(Executive Officer)
Lakeshore Biopharma (Nasdaq: LSB, formerly Yisheng Biopharma) is a biopharmaceutical company focused on developing, producing, and selling vaccines and immunological products for infectious diseases.
BiotechHealthtech
Co-investorsF-Prime Capital
LimmaTech develops vaccine technologies and programs designed to combat antimicrobial-resistant pathogens and prevent severe infections.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAndera PartnersNovo HoldingsTenmile
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.
BiotechMedical DevicesZurich, CH
Co-investorsKurma PartnersPureos BioventuresYsios CapitalFresenius Medical Care VenturesVerve Venturesredalpine
.jpeg){kind=logo}
Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.
BiotechHealthtech
Pete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDavid Mantusin
Co-investorsF-Prime CapitalJeito CapitalLongwood FundSR One Capital ManagementSV Health InvestorsVivo Capital+2 more
Quantoom Biosciences develops Ntensify, an integrated mRNA production solution that combines optimized process chemistry, ready-to-use reagent kits, and specialized equipment to enable cost-effective synthesis and purification of messenger RNA from lab scale to commercial manufacturing.
Advanced ManufacturingAI & Machine LearningBiotechDeep Tech
Jose Castillo, PhD.(Chief Executive Officer)Ashiqul Haque, PhD.(Chief Scientific Officer)
VitriVax develops vaccine technology with a focus on eliminating barriers to global vaccination through expertise in vaccine development, virology, and chemical engineering.
BiotechHealthtech
Romulo Colindres(Chief Executive Officer)Damien Dessis(Chief Business Officer)Bryan Steadman(Chief Technical Officer)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Excision BioThemis BioscienceThemisbioVitriVaxX-Vax Technology
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.